Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Theolytics has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Theolytics's investors include Epidarex Capital, Oxford Science Enterprises, Taiho Ventures, Sound Bioventures, Innovate UK.
Theolytics is headquartered in Oxford, United Kingdom.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Theolytics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Theolytics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/theolytics. Accessed September 30, 2026.
VCBacked. (2026). Theolytics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/theolytics
{{cite web |title=Theolytics — Funding & Investors |url=https://www.vcbacked.co/company/theolytics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated